Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Afya

DB:1AY
Snowflake Description

High growth potential with excellent balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
1AY
DB
$2B
Market Cap
  1. Home
  2. DE
  3. Consumer Services
Company description

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The last earnings update was 12 days ago. More info.


Add to Portfolio Compare Print
  • Afya has significant price volatility in the past 3 months.
1AY Share Price and Events
7 Day Returns
0%
DB:1AY
2.2%
Europe Consumer Services
2.1%
DE Market
1 Year Returns
-
DB:1AY
2.4%
Europe Consumer Services
-16.6%
DE Market
1AY Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Afya (1AY) 0% -2.6% -22.3% - - -
Europe Consumer Services 2.2% -7.2% -6.5% 2.4% -15.6% -55.7%
DE Market 2.1% -12.6% -22.9% -16.6% -21.9% -27.8%
1 Year Return vs Industry and Market
  • No trading data on 1AY.
  • No trading data on 1AY.
Price Volatility
Industry
5yr Volatility vs Market

Value

 Is Afya undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Afya to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Afya.

DB:1AY Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Dividend Discount Model
Dividend Per Share Company Filings (2019-12-31) in BRL R$ 0.69513714285714
Payout Ratio Company Filings (2019-12-31) 2468.9%
Discount Rate (Cost of Equity) See below 7%
Perpetual Growth Rate 10-Year DE Government Bond Rate -0.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:1AY
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate -0.4%
Equity Risk Premium S&P Global 9.3%
Consumer Services Unlevered Beta Simply Wall St/ S&P Global 0.64
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.644 (1 + (1- 34%) (3.32%))
0.771
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= -0.39% + (0.8 * 9.25%)
7.01%

Discounted Cash Flow Calculation for DB:1AY using Dividend Discount Model Model

The calculations below outline how an intrinsic value for Afya is arrived at by discounting future dividends to their present value. This approach is used for finance firms where free cash flow is difficult to estimate (e.g. Banks/ Insurance firms).

If the firm does not pay the majority of its earnings out as a dividend this method will often arrive at a value significantly lower than the share price.

See our documentation to learn about this calculation.

DB:1AY Gordon Growth Model
Calculation Result
Value per share = Expected dividends per share / (Discount Rate - Perpetual growth rate)
= R$0.7 / (7.01% - -0.39%)
R$1.38
DB:1AY Discount to Share Price
Calculation Result
Exchange Rate BRL/USD
(Reporting currency to currency of NasdaqGS:AFYA)
0.191
Value per Share
(USD)
= Value per Share in BRL x Exchange Rate (BRL/USD)
= R$9.39 x 0.191
$1.79
Non-primary Listing Adjustment Factor 1 share in DB:1AY represents 0.87769x of NasdaqGS:AFYA
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.87769x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 1.79 x 0.87769
€1.58
Value per share (EUR) From above. €1.58
Current discount Discount to share price of €18.80
= -1 x (€18.80 - €1.58) / €1.58
-1093.6%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Afya is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Afya's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Afya's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:1AY PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in BRL R$2.03
NasdaqGS:AFYA Share Price ** NasdaqGS (2020-03-31) in USD $21.42
NasdaqGS:AFYA Share Price converted to BRL reporting currency Exchange rate (USD/ BRL) 5.235 R$112.12
Europe Consumer Services Industry PE Ratio Median Figure of 12 Publicly-Listed Consumer Services Companies 15.21x
Germany Market PE Ratio Median Figure of 402 Publicly-Listed Companies 16.83x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Afya.

DB:1AY PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGS:AFYA Share Price ÷ EPS (both in BRL)

= 112.12 ÷ 2.03

55.34x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Afya is overvalued based on earnings compared to the Europe Consumer Services industry average.
  • Afya is overvalued based on earnings compared to the Germany market.
Price based on expected Growth
Does Afya's expected growth come at a high price?
Raw Data
DB:1AY PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 55.34x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts
43.3%per year
Europe Consumer Services Industry PEG Ratio Median Figure of 5 Publicly-Listed Consumer Services Companies 0.33x
Germany Market PEG Ratio Median Figure of 256 Publicly-Listed Companies 1.22x

*Line of best fit is calculated by linear regression .

DB:1AY PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 55.34x ÷ 43.3%

1.28x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Afya is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Afya's assets?
Raw Data
DB:1AY PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in BRL R$23.01
NasdaqGS:AFYA Share Price * NasdaqGS (2020-03-31) in USD $21.42
NasdaqGS:AFYA Share Price converted to BRL reporting currency Exchange rate (USD/ BRL) 5.235 R$112.12
Europe Consumer Services Industry PB Ratio Median Figure of 22 Publicly-Listed Consumer Services Companies 2.18x
Germany Market PB Ratio Median Figure of 573 Publicly-Listed Companies 1.45x
DB:1AY PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGS:AFYA Share Price ÷ Book Value per Share (both in BRL)

= 112.12 ÷ 23.01

4.87x

* Primary Listing of Afya.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Afya is overvalued based on assets compared to the Europe Consumer Services industry average.
X
Value checks
We assess Afya's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Consumer Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Consumer Services industry average (and greater than 0)? (1 check)
  5. Afya has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Afya expected to perform in the next 1 to 3 years based on estimates from 6 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
43.3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Afya expected to grow at an attractive rate?
  • Afya's earnings growth is expected to exceed the low risk savings rate of -0.4%.
Growth vs Market Checks
  • Afya's earnings growth is expected to exceed the Germany market average.
  • Afya's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:1AY Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:1AY Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts 43.3%
DB:1AY Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 6 Analysts 21.8%
Europe Consumer Services Industry Earnings Growth Rate Market Cap Weighted Average 17.7%
Europe Consumer Services Industry Revenue Growth Rate Market Cap Weighted Average 7.1%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14%
Germany Market Revenue Growth Rate Market Cap Weighted Average 3.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:1AY Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
All numbers in BRL Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:1AY Future Estimates Data
Date (Data in BRL Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 1,770 1
2022-12-31 1,602 1
2021-12-31 1,482 389 5
2020-12-31 1,122 295 6
2020-04-08
DB:1AY Past Financials Data
Date (Data in BRL Millions) Revenue Cash Flow Net Income *
2019-12-31 751 299 154
2019-09-30 636 247 128
2019-06-30 520 156 106
2019-03-31 417 120 110
2018-12-31 334 80 86
2017-12-31 216 40 45

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Afya's earnings are expected to grow significantly at over 20% yearly.
  • Afya's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:1AY Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below

All data from Afya Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:1AY Future Estimates Data
Date (Data in BRL Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31 4.56 4.92 4.20 2.00
2020-12-31 3.45 3.87 2.75 3.00
2020-04-08
DB:1AY Past Financials Data
Date (Data in BRL Millions) EPS *
2019-12-31 2.03
2019-09-30 11.15
2019-06-30 47.91
2019-03-31 57.94
2018-12-31 1.84
2017-12-31 1.41

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Afya is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Afya's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Afya has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Afya performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Afya's growth in the last year to its industry (Consumer Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Insufficient data to establish if Afya's year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare Afya's 1-year earnings growth to the 5-year average due to insufficient past data.
  • Afya's earnings growth has exceeded the Europe Consumer Services industry average in the past year (78.2% vs 42.5%).
Earnings and Revenue History
Afya's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Afya Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:1AY Past Revenue, Cash Flow and Net Income Data
Date (Data in BRL Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 750.63 153.92 236.57
2019-09-30 636.02 128.15 177.52
2019-06-30 520.45 106.23 125.68
2019-03-31 417.19 110.38 83.23
2018-12-31 333.94 86.35 70.03
2017-12-31 216.01 45.39 45.36

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Afya has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Afya used its assets less efficiently than the Europe Consumer Services industry average last year based on Return on Assets.
  • Unable to establish if Afya improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to insufficient past data.
X
Past performance checks
We assess Afya's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Consumer Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Afya has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Afya's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Afya's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Afya is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Afya's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Afya's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 18.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Afya Company Filings, last reported 3 months ago.

DB:1AY Past Debt and Equity Data
Date (Data in BRL Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 2,113.73 61.11 943.21
2019-09-30 2,055.02 82.19 993.62
2019-06-30 1,069.69 98.49 68.67
2019-03-31 1,054.09 81.87 245.32
2018-12-31 590.35 77.83 62.82
2017-12-31 46.76 3.93 25.49
  • Afya's level of debt (2.9%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Afya's debt level has increased without past 5-year debt data.
  • Debt is well covered by operating cash flow (489.6%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 10.1x coverage).
X
Financial health checks
We assess Afya's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Afya has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Afya's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Afya dividends. Estimated to be 0.62% next year.
If you bought €2,000 of Afya shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Afya's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Afya's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:1AY Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
Europe Consumer Services Industry Average Dividend Yield Market Cap Weighted Average of 7 Stocks 2.6%
Germany Market Average Dividend Yield Market Cap Weighted Average of 314 Stocks 3.7%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 4.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:1AY Future Dividends Estimate Data
Date (Data in R$) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31 1.07 3.00
2020-12-31 0.41 4.00
2020-04-08

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Afya has not reported any payouts.
  • Unable to verify if Afya's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Afya's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Afya has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Afya's dividends in 3 years as they are not expected to pay a notable one for Germany.
X
Income/ dividend checks
We assess Afya's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Afya afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Afya has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Afya's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Virgilio Deloy Gibbon
AGE 44
TENURE AS CEO 0.8 years
CEO Bio

Mr. Virgilio Deloy Capobianco Gibbon is Chief Executive Officer of Afya Limited since June 2019. He has been the Chief Executive Officer of Afya Brazil since August 2016. Prior to joining us, he was Chief Operating Officer and Chief Financial Officer of Estácio Participação S.A., from March 2010 to March 2012, and March 2012 to June 2016, respectively. He was also Executive Director of Business Consulting and Education Industry at TOTVS Consulting from October 2007 to December 2009, and Senior Manager of Business Consulting at Accenture from 2000 to 2007. He holds a degree in Economics from PUC-RJ. He is currently a board member of EABH – Escola Americana of Belo Horizonte.

CEO Compensation
  • Insufficient data for Virgilio Deloy to compare compensation growth.
  • Insufficient data for Virgilio Deloy to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Afya management team in years:

0.8
Average Tenure
44
Average Age
  • The average tenure for the Afya management team is less than 2 years, this suggests a new team.
Management Team

Virgilio Deloy Gibbon

TITLE
Chief Executive Officer
AGE
44
TENURE
0.8 yrs

Luciano de Campos

TITLE
Chief Financial Officer
AGE
44
TENURE
0.8 yrs

Renata Couto

TITLE
Investor Relations Executive Manager

Julio Eduardo de Angeli

TITLE
Vice President of Continuing Education & Innovation
AGE
46
TENURE
0.8 yrs
Board of Directors Tenure

Average tenure and age of the Afya board of directors in years:

0.8
Average Tenure
43
Average Age
  • The average tenure for the Afya board of directors is less than 3 years, this suggests a new board.
Board of Directors

Nicolau Esteves

TITLE
Chairman
AGE
66
TENURE
0.8 yrs

Vanessa Lopes

TITLE
Independent Director
AGE
43
TENURE
0.8 yrs

Renato Esteves

TITLE
Director
AGE
31
TENURE
0.8 yrs

Sérgio Mendes Coutinho

TITLE
Director
AGE
41
TENURE
0.8 yrs

Daniel Borghi

TITLE
Director
AGE
45
TENURE
0.8 yrs

Laura Carvalho

TITLE
Director
AGE
36
TENURE
0.8 yrs

Felipe Argalji

TITLE
Director
AGE
31
TENURE
0.8 yrs

Daulins Emilio

TITLE
Non-Independent Director
AGE
45
TENURE
0.7 yrs

Rafael de Almeida

TITLE
Independent Director
AGE
43
TENURE
0.7 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Afya's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Afya has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, physical education, nursing, civil and mechanical engineering, industrial engineering, dentistry, pedagogy, nutrition, advertising, electrical engineering, physical therapy, psychology, and software engineering. In addition, the company provides distance learning residency preparatory courses through its online platform; and develops and sells printed and digital medical education content. As of September 30, 2019, it operated a network of 19 undergraduate and graduate medical school campuses. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

Details
Name: Afya Limited
1AY
Exchange: DB
Founded: 1999
$1,837,387,433
92,764,203
Website: http://www.afya.com.br
Address: Afya Limited
No. 119, Alameda Oscar Niemeyer,
Salas 502, 504, 1,501 and 1,503,
Nova Lima,
Minas Gerais, Brazil
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGS AFYA Class A Common Stock Nasdaq Global Select US USD 19. Jul 2019
DB 1AY Class A Common Stock Deutsche Boerse AG DE EUR 19. Jul 2019
Number of employees
Current staff
Staff numbers
2,705
Afya employees.
Industry
Education Services
Consumer Services
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/08 02:26
End of day share price update: 2020/03/31 00:00
Last estimates confirmation: 2020/03/27
Last earnings filing: 2020/03/27
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.